|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2022
Haschka, Stefanie J.; Gar, Christina; Sacco, Vanessa; Banning, Friederike; Ferrari, Uta; Freibothe, Ines; Kern-Matschilles, Stefanie; Potzel, Anne L.; Rauch, Barbara; Füessl, Louise U.; Meisel, Mandy; Benz, Irina; Then, Cornelia; Seissler, Jochen und Lechner, Andreas
(2022):
Pre-diabetes, diabetes and fluctuations of glucose tolerance after gestational diabetes mellitus: 5-year follow-up of a contemporary, prospective study in Germany.
In: BMJ Open Diabetes Research & Care, Bd. 10, Nr. 2
[PDF, 951kB]
Kern-Matschilles, Stefanie; Gar, Christina; Schilbach, Katharina; Haschka, Stefanie Julia; Rauch, Barbara; Then, Cornelia; Seissler, Jochen; Bidlingmaier, Martin und Lechner, Andreas
(2022):
Altered Circulating Leptin, hGH, and IGF-I in Prediabetes and Screening-Diagnosed T2DM Unrelated to Metabolic Syndrome in Women Post Gestational Diabetes.
In: Hormone and Metabolic Research, Bd. 54, Nr. 9: S. 613-619
2021
Gar, Christina; Haschka, Stefanie J.; Kern-Matschilles, Stefanie; Rauch, Barbara; Sacco, Vanessa; Prehn, Cornelia; Adamski, Jerzy; Seissler, Jochen; Wewer Albrechtsen, Nicolai J.; Holst, Jens J. und Lechner, Andreas
(2021):
The liver-alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels.
In: Diabetologia, Bd. 64, Nr. 3: S. 512-520
[PDF, 854kB]
2020
Sacco, Vanessa; Rauch, Barbara; Gar, Christina; Haschka, Stefanie; Potzel, Anne L.; Kern-Matschilles, Stefanie; Banning, Friederike; Benz, Irina; Meisel, Mandy; Seissler, Jochen und Lechner, Andreas
(2020):
Overweight/obesity as the potentially most important lifestyle factor associated with signs of pneumonia in COVID-19.
In: PLOS One 15(11), e0237799 [PDF, 654kB]
In: PLOS One 15(11), e0237799 [PDF, 654kB]
2014
Schmidt, Laura; Winkel, Mark op den; Fischer, Katharina; Straub, Gundula; Rauch, Barbara; Paprottka, Philipp Marius; Göke, Burkhard und Kolligs, Frank Thomas
(2014):
Addition of local hepatic therapy to sorafenib in patients with advanced hepatocellular carcinoma (stage BCLC C).
In: Digestion, Bd. 90, Nr. 4: S. 219-228
[PDF, 189kB]